A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Isradipine | CAS 75695-93-1 - Request Quote

Picture of Isradipine
SZ CAT No:SZ-I069001
CAS No
75695-93-1
Mol.F.
C19H21N3O5
Mol.Wt.
371.4
Inv. Status
Synthesis on demand
Rel. CAS No2900275-74-1 (HCl salt)
Shipping Condition Room Temperature

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Isradipine is chemically 3-Methyl 5-(propan-2-yl) (4RS)-4-(2,1,3-benzoxadiazol-4-yl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate (as per EP). Isradipine is supplied with detailed characterization data compliant with regulatory guideline. Isradipine can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Isradipine.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

Buy 75695-93-1

Purchase 75695-93-1

Order 75695-93-1

Enquire 75695-93-1

price of 75695-93-1

75695-93-1 Supplier

75695-93-1 Manufacturer

75695-93-1 Exporter

buy high quality Isradipine

Purchase Isradipine

Isradipine suppliers

Isradipine manufacturers

Isradipine price

Order Isradipine

Enquire Isradipine

Isradipine cost

Isradipine Supplier

Isradipine Distributor

Isradipine for Method Validation

Isradipine Reference Standard

Isradipine for ANDA Filing

Isradipine for Forced Degradation Studies

Isradipine Identification Standards

Isradipine for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,